Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs. (Q37962449)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2012

Language	Label	Description	Also known as
English	Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.	scientific article published on February 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

anti-retroviral agent

0 references

drug interaction

0 references

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Michelle Foisy

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 February 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Current infectious disease reports

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

67-82

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immunodeficiency virus-infected patients with lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Excessive neurotoxicity with ABVD when combined with protease inhibitor-based antiretroviral therapy in the treatment of AIDS-related Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Deleterious pharmacokinetic interaction between bexarotene and efavirenz

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Raltegravir-based HAART regimen in a patient with large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Pharmacokinetic enhancement of the hepatitis C virus protease inhibitors VX-950 and SCH 503034 by co-dosing with ritonavir

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Interactions between antifungal and antiretroviral agents

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Complexity of interactions between voriconazole and antiretroviral agents

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Effect of rifampin on plasma concentrations of mefloquine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Iatrogenic Cushing's syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Metabolic derangement after injection of triamcinolone into the hip of an HIV-infected patient receiving ritonavir.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Cushing's syndrome and adrenal axis suppression in a patient treated with ritonavir and corticosteroid eye drops.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Toxicokinetic interaction between quetiapine and antiretroviral therapy following quetiapine overdose

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Lack of clinically significant drug interactions between nevirapine and buprenorphine

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Implanon failure in patients on antiretroviral medication: the importance of disclosure

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Drug interactions with antiretrovirals and warfarin

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Pulmonary hypertension and human immunodeficiency virus infection: epidemiology, pathogenesis, and clinical approach

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Successful bosentan and nonnucleoside reverse transcriptase inhibitor-based therapy in a patient with acquired immunodeficiency syndrome and pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Mutual pharmacokinetic interactions between bosentan and lopinavir/ritonavir in healthy participants

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Possible reduction in indinavir serum concentrations by bosentan

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Interaction involving tadalafil and CYP3A4 inhibition by ritonavir.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Pharmacokinetic interactions between etravirine and non-antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medications

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs.

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Evaluation of HIV drug interaction web sites

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

iAIDS: HIV-related internet resources for the practicing clinician

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Successful switch to sitaxsentan in a patient with HIV-related pulmonary arterial hypertension and late intolerance to nonselective endothelin receptor blockade

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Recognition of Risk for Clinically Significant Drug Interactions among HIV‐Infected Patients Receiving Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0229-1

21 January 2018

Adrenal suppression and Cushing's syndrome secondary to ritonavir and budesonide

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of drug interactions in patients with HIV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction between antiretroviral drugs and acenocoumarol

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cushing's syndrome due to antiretroviral-budesonide interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22125049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11908-011-0229-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125049%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37962449&oldid=1547679693"